Judith S Hecker

8PUBLICATIONS
90CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 22, 2026
Proteomic and proteogenomic identification of targetable T-cell antigens in multiple myeloma.

|Jul 10, 2025
Boosting CAR T-cell efficacy by blocking proteasomal degradation of membrane antigens.

Leonie Rieger, Kilian Irlinger, Franziska Füchsl

|Jun 12, 2025
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST.

Maximilian Merz, Nico Gagelmann, Samih Smaili

|Aug 19, 2024
Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantation.

Theresa Landspersky, Merle Stein, Mehmet Saçma

|Aug 18, 2022
Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML.

Maike Roas, Binje Vick, Marc-André Kasper

|Oct 17, 2021
Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress.

Theresa Landspersky, Mehmet Saçma, Jennifer Rivière

Pageof 2

Frequent Collaborators

4 joint publications

Katharina S Götze

3 joint publications

Jennifer Rivière

2 joint publications

Johannes M Waldschmidt

2 joint publications

Karsten Spiekermann